Jubilant Ingrevia Ltd
Jubilant Ingrevia Q2 Results 2026 (FY27): Revenue ₹1,394 Cr, PAT ₹111 Cr
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Jubilant Ingrevia Ltd Q2 FY27 key numbers
- Revenue
- Q2’FY27 total revenue from operations: ₹1,394 crore, up 24% YoY.
As stated in Jubilant Ingrevia Ltd's Q2 FY27 investor presentation · published 27 Oct 2026. Reported figures, not investment advice.
Based on Jubilant Ingrevia Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2’FY27 total revenue from operations: ₹1,394 crore, up 24% YoY (Page 2, 7, 16, 27, 28) - Sales/Income from operations: ₹1,381 crore, up 24% YoY (Page 7, 27) - Segment revenues Q2’FY27 (₹ crore) a EBITDA for Q2 FY27: Rs 221 crore, up 51% YoY - EBITDA Margin for Q2 FY27: 16%, compared to 13% in Q2 FY26 - Profit After Tax (PAT) for Q2 FY27: Rs 111 crore, up 61% YoY - Operating M
From Jubilant Ingrevia Ltd's Q2 FY27 earnings-call transcript · updated 27 Oct 2026.
Revenue & Sales Performance
- Q2’FY27 total revenue from operations: ₹1,394 crore, up 24% YoY (Page 2, 7, 16, 27, 28)
- Sales/Income from operations: ₹1,381 crore, up 24% YoY (Page 7, 27)
- Segment revenues Q2’FY27 (₹ crore) and YoY growth:
- Speciality Chemicals: 560, +16%
- Nutrition & Health Solutions: 270, +50%
- Chemical Intermediates: 563, +24% (Page 23, 27, 28)
- Volume remarks:
- Stable volumes overall amid geopolitical uncertainties (Page 2)
- Strong volume growth in Nutrition (Vitamin B3: double-digit growth YoY and QoQ) (Page 4, 22)
- Steady volumes in Chemical Intermediates; growth supported by pharma demand and market share gains (Page 4, 23)
- Outlook:
- Growth expected across all three segments in FY27 (Page 3)
2 more points from Jubilant Ingrevia Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
- EBITDA for Q2 FY27: Rs 221 crore, up 51% YoY
- EBITDA Margin for Q2 FY27: 16%, compared to 13% in Q2 FY26
- Profit After Tax (PAT) for Q2 FY27: Rs 111 crore, up 61% YoY
- Operating Margin (Net Margin) for Q2 FY27: 8%, up from 6% in Q2 FY26
Capital Expenditure Plans
Fundraising & Capital Structure
See what Jubilant Ingrevia Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Jubilant Ingrevia Ltd's call on order book
Create a free account to keep reading this call
Jubilant Ingrevia Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.4K Cr, net profit ₹111 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Jubilant Ingrevia Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Diamines & Chemicals Ltd (Q2 FY27)
Revenue from operations for the quarter ended 30th September 2026 is ₹986.84 lakhs (consolidated) and ₹984.37 lakhs (standalone). Key results statement takeaway
- Pidilite Inds. (Q2 FY27)
Q2 FY27 Net Sales (Consolidated): Rs 4,285 Cr, up 21.1% YoY (Page 28, 12) . Key investor presentation takeaways from Pidilite Industries Ltd's Q2 FY27 investor
- Yasho Industries Ltd (Q2 FY27)
Q2 FY27 revenue from operations: ₹347.68 crore, up 90% YoY from Q2 FY26 ₹183.30 crore (Page 21). Key investor presentation takeaways from Yasho Industries Ltd's
- Styrenix Performance Materials Ltd (Q2 FY27)
Q2 FY27 Revenue from Operations (Consolidated): ₹993.5 crores, up 24.4% YoY from ₹798.9 crores in Q2 FY26 . Key investor presentation takeaways from Styrenix Pe
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Jubilant Ingrevia Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Jubilant Ingrevia Ltd Q2 FY27 results?
Q2’FY27 total revenue from operations: ₹1,394 crore, up 24% YoY (Page 2, 7, 16, 27, 28) - Sales/Income from operations: ₹1,381 crore, up 24% YoY (Page 7, 27) - Segment revenues Q2’FY27 (₹ crore) a EBITDA for Q2 FY27: Rs 221 crore, up 51% YoY - EBITDA Margin for Q2 FY27: 16%, compared to 13% in Q2 FY26 - Profit After Tax (PAT) for Q2 FY27: Rs 111 crore, up 61% YoY - Operating M
What is Jubilant Ingrevia Ltd share price analysis?
Jubilant Ingrevia Ltd currently shows a neutral. The stock trades at a P/E of 30.4 with a market cap of ₹9,651 Cr. Investors should review the full earnings analysis for detailed insights.
Is Jubilant Ingrevia Ltd planning capital expenditure?
Acquisition of 40% stake in ZettaOne Technologies India Pvt.
Keep Jubilant Ingrevia Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.